Related Experiment Video

Updated: Dec 18, 2025

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

14.0K

Gene expression of transforming growth factor beta receptors I and II in non-small-cell lung tumors

Antonella Colasante1, Francesca B Aiello, Mauro Brunetti

  • 1Department of Oncology and Neuroscience, G. D'Annunzio University, Anatomia Patologica, Ospedale SS. Annunziata, Via dei Vestini, 66013, Chieti, Italy. acolasante@unich.it

Cytokine
|November 5, 2003
PubMed

Insights

Transforming growth factor-beta (TGF-β) receptor expression differs in non-small cell lung cancer. This study found altered TGF-β receptor levels in lung tumors, suggesting a role in cancer progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Transforming growth factor-beta (TGF-β) signaling regulates epithelial cell proliferation and is often dysregulated in cancer.
  • Decreased TGF-β receptor (TbetaR) expression correlates with reduced TGF-β sensitivity and increased tumor progression.
  • Non-small cell (NSC) lung cancer, a leading cause of cancer mortality, requires further investigation into TbetaR expression patterns.

Purpose of the Study:

  • To comparatively analyze the messenger RNA (mRNA) and protein expression of TGF-β receptors (TbetaRI and TbetaRII) in non-small cell lung tumors and adjacent non-lesional lung tissues.
  • To investigate the potential association between TbetaR expression and tumor progression in NSC lung cancer.

Main Methods:

  • Tissue samples from 17 patients with primary NSC lung tumors (clinical stage II) and control non-lesional lung tissues were analyzed.
  • Semi-quantitative reverse transcription-PCR was used to assess TbetaRI and TbetaRII mRNA levels.
  • Quantitative immunohistochemistry was employed to evaluate TbetaRI and TbetaRII protein expression.

Main Results:

  • TbetaRI protein expression was significantly higher in tumors compared to controls (p=0.0005), with a similar trend observed at the mRNA level.
  • TbetaRII protein expression showed no significant difference between tumors and controls, but intense peri-nuclear staining was noted in tumor cells.
  • TbetaRII mRNA levels were significantly lower in tumors than in controls (p=0.005), and an inverse correlation between TbetaRII mRNA and protein expression was found in tumors (p=0.0013).

Conclusions:

  • The findings suggest an altered expression and potential functional changes of the TGF-β receptor system in non-small cell lung cancer.
  • These alterations in TbetaR expression may contribute to the loss of TGF-β sensitivity and enhanced tumor progression observed in NSC lung cancer.

More Related Videos

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling07:49

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

11.6K
Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System11:06

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System

Published on: July 30, 2018

11.0K

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.2K